Top Biomed Stock
Report Date: 04-17-2022
Symbol: BCAB - BioAtla, Inc.
Sector:
Industry:
Top Biomed Stock Signal: BCAB
BioAtla, Inc. (BCAB)
11085 Torreyana Road
San Diego, CA 92121
Phone: 858 558 0708
Website: http://www.bioatla.com
CEO: Dr. Jay M. Short
BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of various cancers. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and other tumor types. It also develops BA3021, a CAB ADC for NSCLC and Melanoma; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. The company was founded in 2007 and is based in San Diego, California.